UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$453M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$287M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$284M |
| 4 |
PPL
PPL Corp
PPL
|
+$262M |
| 5 |
Western Digital
WDC
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$641M |
| 2 |
Microsoft
MSFT
|
+$477M |
| 3 |
Accenture
ACN
|
+$354M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$332M |
| 5 |
Chevron
CVX
|
+$304M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.68% |
| 2 | Healthcare | 7.02% |
| 3 | Financials | 6.95% |
| 4 | Consumer Discretionary | 5.19% |
| 5 | Industrials | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KDNY
4751
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $248K | ﹤0.01% |
14,126
-60,288
| -81% | -$946K |
|
4752
PUT
Bausch Health
BHC
$2.33B
| $247K | ﹤0.01% |
29,500
| – | – |
|
|
LBAI
4753
DELISTED
Lakeland Bancorp Inc
LBAI
| $247K | ﹤0.01% |
16,842
-13,714
| -45% | -$210K |
|
|
BIOS
4754
DELISTED
BioPlus Acquisition Corp. Class A Ordinary Shares
BIOS
| $247K | ﹤0.01% |
24,750
-250
| -1% | -$2.48K |
|
4755
State Street SPDR MSCI ACWI Climate Paris Aligned ETF
NZAC
$198M
| $246K | ﹤0.01% |
9,422
+50
| +0.5% | +$1.41K |
|
4756
Andersons Inc
ANDE
$2.18B
| $245K | ﹤0.01% |
7,419
-5,188
| -41% | -$221K |
|
4757
First Busey Corp
BUSE
$2.57B
| $245K | ﹤0.01% |
10,707
-9,308
| -47% | -$216K |
|
4758
ProShares High Yield-Interest Rate Hedged ETF
HYHG
$194M
| $245K | ﹤0.01% |
4,307
-34,322
| -89% | -$2.06M |
|
4759
PUT
PG&E
PCG
$38.1B
| $245K | ﹤0.01% |
24,500
-175,500
| -88% | -$2.06M |
|
|
QDYN
4760
DELISTED
FlexShares Quality Dividend Dynamic Index Fund
QDYN
| $245K | ﹤0.01% |
4,618
+178
| +4% | +$10.5K |
|
4761
Invesco MSCI Global Timber ETF
CUT
$33.6M
| $244K | ﹤0.01% |
7,883
-36
| -0.5% | -$1.23K |
|
4762
TriSalus Life Sciences
TLSI
$353M
| $244K | ﹤0.01% |
24,817
+24,694
| +20,076% | +$243K |
|
4763
Cato Corp
CATO
$65.3M
| $243K | ﹤0.01% |
20,940
-5,101
| -20% | -$67.1K |
|
|
FOXO
4764
DELISTED
FOXO TECHNOLOGIES INC A
FOXO
| $243K | ﹤0.01% |
+122
| New | +$242K |
|
4765
Global Indemnity Group
GBLI
$407M
| $243K | ﹤0.01% |
9,407
-25
| -0.3% | -$656 |
|
4766
Ternium
TX
$10.7B
| $243K | ﹤0.01% |
6,727
+252
| +4% | +$10.7K |
|
4767
Calix
CALX
$2.49B
| $242K | ﹤0.01% |
7,099
-69,775
| -91% | -$2.59M |
|
|
JHI
4768
John Hancock Investors Trust
JHI
$118M
| $242K | ﹤0.01% |
18,390
-18,005
| -49% | -$269K |
|
4769
NeoGenomics
NEO
$2.12B
| $241K | ﹤0.01% |
29,539
-22,430
| -43% | -$214K |
|
|
TDF
4770
Templeton Dragon Fund
TDF
$278M
| $241K | ﹤0.01% |
16,893
+1,177
| +7% | +$14.9K |
|
|
VMEO
4771
DELISTED
Vimeo
VMEO
| $240K | ﹤0.01% |
39,974
-31,846
| -44% | -$289K |
|
4772
Ennis
EBF
$560M
| $239K | ﹤0.01% |
11,838
-231,776
| -95% | -$4.18M |
|
4773
National Vision
EYE
$1.77B
| $239K | ﹤0.01% |
8,680
-1,083
| -11% | -$35.7K |
|
4774
Quanterix
QTRX
$124M
| $239K | ﹤0.01% |
14,756
+201
| +1% | +$4.13K |
|
4775
Albany International
AIN
$1.79B
| $238K | ﹤0.01% |
3,017
-29,363
| -91% | -$2.39M |
|
Similar funds
UBS Group's Q2 2022 Portfolio in Review
As of Q2 2022, UBS Group held 11,816 positions worth $244B, down 19% from $300B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group withdrew a net $9.23B in Q2 2022, closing 1,052 positions and reducing 5,054 holdings. Its most notable exit was Cerner Corp, an estimated $177M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.
Against the trend, UBS Group opened a new position in iShares 0-3 Month Treasury Bond ETF worth $13.8M.
- UBS Group's largest Q2 2022 buy was iShares 0-3 Month Treasury Bond ETF: 137,765 shares worth $13.8M.
- UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $453M increase.
- UBS Group's biggest Q2 2022 reduction was Apple, cutting an estimated $641M.
- UBS Group fully exited Cerner Corp in Q2 2022, selling an estimated $177M.
- UBS Group's ten largest holdings make up 13% of its $244B portfolio in Q2 2022.
- UBS Group opened 1,264 new positions and closed 1,052 in Q2 2022.
- UBS Group's portfolio value fell 19% quarter-over-quarter to $244B.
Based on UBS Group's 13F filing for Q2 2022, filed 10 Aug 2022.